Terkko Navigator / -/ Feeds / " ( ( Ras-proteiinit )|( Ras-proteiini )|( ras Proteins )|( Gene Products, ras )|( ras Gene"

NRAS is unique among RAS proteins in requiring ICMT for trafficking to the plasma membrane

Small Molecule Destabilizer ofβ-Catenin and Ras Proteins Antagonizes Growth of K-Ras Mutation-Driven Colorectal Cancers Resistant to EGFR Inhibitors

Ras Diffusion and Interactions with the Plasma Membrane Measured by FRAP Variations

Novel regulation of Ras proteins by direct tyrosine phosphorylation and dephosphorylation

Cancers, Vol. 12, Pages 3326: Proximal Protein Interaction Landscape of RAS Paralogs

Cancers, Vol. 12, Pages 3326: Proximal Protein Interaction Landscape of RAS Paralogs

Biomolecules, Vol. 10, Pages 1535: Natural Products Attenuating Biosynthesis, Processing, and Activity of Ras Oncoproteins: State of the Art and Future Perspectives

Biomolecules, Vol. 10, Pages 1535: Natural Products Attenuating Biosynthesis, Processing, and Activity of Ras Oncoproteins: State of the Art and Future Perspectives

An expanded classification of active, inactive, and druggable RAS conformations

RAS and PP2A activities converge on epigenetic gene regulation

Genes, Vol. 12, Pages 1094: The Importance of Being PI3K in the RAS Signaling Network

Validation of a small molecule inhibitor of PDE6D-RAS interaction with potent anti-leukemic effects

CSIG-02. R-RAS SUBFAMILY PROTEINS ELICIT DISTINCT PHYSIOLOGIC EFFECTS AND PHOSPHOPROTEOME ALTERATIONS IN NEUROFIBROMIN-NULL MPNST CELLS

Promising Molecular Targets for Design of Antitumor Drugs Based on Ras Protein Signaling Cascades

Molecular Dynamics Simulation of Lipid-Modified Signaling Proteins

Cell-permeable CaaX-peptides affect K-Ras downstream signaling and promote cell death in cancer cells.

Inhibiting the "Undruggable" RAS/Farnesyltransferase (FTase) Cancer Target by Manumycin-related Natural Products

Using BioID to Characterize the RAS Interactome

Analysis of the H-Ras mobility pattern in vivo shows cellular heterogeneity inside epidermal tissue

Long-lasting Salt Bridges Provide the Anchoring Mechanism of Oncogenic Kirsten Rat Sarcoma Proteins at Cell Membranes.

Ras GEF Mouse Models for the Analysis of Ras Biology and Signaling

IJMS, Vol. 23, Pages 3706: Small-Molecule RAS Inhibitors as Anticancer Agents: Discovery, Development, and Mechanistic Studies

NMR in integrated biophysical drug discovery for RAS: past, present, and future

RAS GTPase signalling to alternative effector pathways.

Genes, Vol. 12, Pages 662: The Role of Wild-Type RAS in Oncogenic RAS Transformation

RASless MEFs as a Tool to Study RAS-Dependent and RAS-Independent Functions

Inhibition of mutant RAS-RAF interaction by mimicking structural and dynamic properties of phosphorylated RAS

Binding of Ras to Phosphoinositide 3-Kinase p110alpha Is Required for Ras- Driven Tumorigenesis in Mice.

The R-Ras/RIN2/Rab5 complex controls endothelial cell adhesion and morphogenesis via active integrin endocytosis and Rac signaling.

High-Throughput Dual Screening method for Ras Activities and Inhibitors.

High-Throughput Dual Screening Method for Ras Activities and Inhibitors.

Dynamically encoded reactivity of Ras enzymes: opening new frontiers for drug discovery

Oncogenic Ras disrupts epithelial integrity by activating the transmembrane serine protease hepsin.

Oncogenic Ras disrupts epithelial integrity by activating the transmembrane serine protease hepsin.

Oncogenic Ras disrupts epithelial integrity by activating the transmembrane serine protease hepsin.

Oncogenic Ras disrupts epithelial integrity by activating the transmembrane serine protease hepsin.

Oncogenic Ras Disrupts Epithelial Integrity by Activating the Transmembrane Serine Protease Hepsin

Oncogenic Ras Disrupts Epithelial Integrity by Activating the Transmembrane Serine Protease Hepsin

High-Throughput Dual Screening Method for Ras Activities and Inhibitors

Probing RAS Function with Monobodies

FLIM-FRET Analysis of Ras Nanoclustering and Membrane-Anchorage

Super-Resolution Imaging and Spatial Analysis of RAS on Intact Plasma Membrane Sheets

Ras isoform-specific expression, chromatin accessibility, and signaling

RAS mutation patterns arise from tissue-specific responses to distinct oncogenic signaling

Oncogenic Ras Disrupts Epithelial Integrity by Activating the Transmembrane Serine Protease Hepsin

Oncogenic Ras Disrupts Epithelial Integrity by Activating the Transmembrane Serine Protease Hepsin

Genes, Vol. 12, Pages 819: The Crossroads between RAS and RHO Signaling Pathways in Cellular Transformation, Motility and Contraction

Cancers, Vol. 12, Pages 3143: A Gene Expression High-Throughput Screen (GE-HTS) for Coordinated Detection of Functionally Similar Effectors in Cancer

Validation of Isoform- and Mutation-Specific RAS Antibodies

Horizontal gene transfers and cell fusions in microbiology, immunology and oncology (Review).